Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Palo Alto Networks Inc — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.65 (market cap $977.37M), while Palo Alto Networks Inc trades at $365.6 (market cap $306.78B). The key difference: Palo Alto Networks Inc is far larger — about 313.9× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Palo Alto Networks Inc for 82 Days on average.
| MRVI | PANW | |
|---|---|---|
Market Cap | $977.37M | $306.78B |
Volume | 2,742,564 | 7,147,609 |
Sector | Health | Technology |
52-Week High | $9.00 | $419.91 |
52-Week Low | $2.83 | $141.67 |
Typical Hold Time | 0 Days | 82 Days |
Enterprise Value | $1.08B | $306.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Palo Alto Networks trades at $397.03, down 1.68% on the day but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Revenue growth continues at $9.22 billion for 2025, though valuation metrics remain elevated with a P/E of 937.6. Recent AI security developments and platformization strategy are driving positive analyst sentiment.
The outlook remains positive given strong AI-driven cybersecurity demand and consistent earnings beats, though premium valuation and rising costs present risks. Analyst consensus targets $400.05 with 72% buy ratings, suggesting modest upside potential from current levels amid growing enterprise security spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
